US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 64.410
  • +0.650+1.02%
Close Apr 28 16:00 ET
  • 64.900
  • +0.490+0.76%
Pre 09:18 ET
4.07BMarket Cap-14.84P/E (TTM)

About Rhythm Pharmaceuticals Company

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Company Profile

SymbolRYTM
Company NameRhythm Pharmaceuticals
Listing DateOct 5, 2017
Issue Price17.00
Founded2008
CEODr. David P. Meeker,M.D.
MarketNASDAQ
Employees283
Fiscal Year Ends12-31
Address222 Berkeley Street,12th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116-3748
Phone1-857-264-4280

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David P. Meeker,M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 7.23M
  • Pamela J. Cramer
  • Chief Human Resources Officer
  • --
  • Joseph Shulman
  • Chief Technical Officer
  • 1.74M
  • Hunter C. Smith
  • Chief Financial Officer and Treasurer
  • 2.31M
  • Christopher P. German
  • Director, Corporate Controller and Principal Accounting Officer
  • --
  • Jennifer Lee
  • Executive Vice President and Head of North America
  • 2.11M
  • Yann Mazabraud
  • Executive Vice President and Head of International
  • 1.74M
  • Lynn A. Tetrault, J.D.
  • Independent Director
  • 298.77K
  • Jennifer L. Good
  • Independent Director
  • 283.77K
  • Stuart A. Arbuckle
  • Independent Director
  • 301.27K
  • Edward T. Mathers
  • Lead Independent Director
  • 328.77K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 308.77K
  • Christophe R. Jean
  • Independent Director
  • 293.77K
  • Dr. Camille L. Bedrosian,M.D.
  • Independent Director
  • 296.27K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.